Your browser doesn't support javascript.
loading
The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study.
Bae, Sang-Cheol; Bass, Damon L; Chu, Myron; Curtis, Paula; Dimelow, Richard; Harvey, Laurence; Ji, Beulah; Kurrasch, Regina; Muzaffar, Saima; Punwaney, Raj; Roth, David A; Song, Yeong-Wook; Xie, Wendy; Zhang, Fengchun.
Afiliação
  • Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases and Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
  • Bass DL; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Chu M; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Curtis P; Department of Development Biostatistics, GlaxoSmithKline, Brentford, Middlesex, UK.
  • Dimelow R; Clinical Pharmacology, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
  • Harvey L; Immunoinflammation R&D, GlaxoSmithKline, Brentford, Middlesex, UK.
  • Ji B; Immunoinflammation R&D, GlaxoSmithKline, Brentford, Middlesex, UK.
  • Kurrasch R; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Muzaffar S; Clinical Development, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. smuzaffar639@gmail.com.
  • Punwaney R; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Roth DA; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Song YW; Division of Rheumatology, Seoul National University Hospital, Seoul National University, Seoul, Republic of Korea.
  • Xie W; Immunoinflammation, GlaxoSmithKline, Collegeville, PA, USA.
  • Zhang F; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Arthritis Res Ther ; 24(1): 46, 2022 02 16.
Article em En | MEDLINE | ID: mdl-35172878
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article